Addictive behaviors, cardiovascular and metabolic comorbidities in North African psoriatic patients: case-control study

Aounallah, A.; Mernissi, F.Z.; Dahmani, B.; Bougmiza, Iheb; Houria, Sahel; Bouadjar, Bacar; Benkaidali, I.; Ammar-Khodja, A; Serradj, A.; Titi, A; Hassam, Badreddine; Benchikhi, H.; Amal, S.; Dhaoui, Raouf; Turki, H.; Mokhtar,; Doss, N.; Denguezli, M.

doi:10.11604/pamj.2019.34.205.12883

Cited by 6 publications

(5 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One study 49 reported the prevalence of any type of psoriasis among patients. The study design distribution for the included studies was as follows: 23 cross‐sectional studies, 18,21,25,26,28,29,31–34,36,43,44,46,47,49,51,52,56,57,59 20 case–control studies, 15–17,19,20,22,24,25,27,30,38–42,45,48,54,55 ono cohort study, 53 and one HUNT study 50 . These studies included six different internationally available diagnostic criteria for MetS, including the National Cholesterol Education Program's Adult Treatment Panel III (NCEP‐ATP III); Chinese Diabetes Society (CDS) definition of MetS; Harmonized Definition of Metabolic Syndrome (HDMS); International Classification of Diseases, Ninth Revision (ICD‐9); National Heart, Lung and Blood Institute and American Heart Association (NHLKI and AHA); International Diabetes Federation definition of metabolic syndrome (IDF); and IDF children (Table 1).…”

Section: Resultsmentioning

confidence: 99%

“…All studies reported the pooled prevalence of MetS among patients with psoriasis; of them, 15 described this prevalence in men and women, 38 reported the prevalence in adults, 15–22,24–26,28,29,31–36,38,40–44,46–52,54–57,59 and 4 reported the prevalence in children and teenagers 30,37,53,58 . Fifteen studies 17,19–22,32,34,37,38,40,44,45,49,50,59 analysed the prevalence of combined MetS in patients with mild, moderate and severe psoriasis.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Global prevalence of metabolic syndrome in patients with psoriasis in the past two decades: current evidence

Liu

Cai

Sun

et al. 2022

Acad Dermatol Venereol

View full text Add to dashboard Cite

Patients with psoriasis are at an increased risk of metabolic syndrome (MetS); however, a systematic analysis of its global prevalence has not been performed to date. Here, we performed a systematic review and meta‐analysis to assess the prevalence of MetS among patients with psoriasis. We searched five databases from inception through September 2021 and used the Agency for Healthcare Research and Quality (AHRQ) and Newcastle–Ottawa Scale (NOS) tools to assess observational study quality. Stata SE 15.1 was used to perform the data analysis. Subgroup, meta‐regression and sensitivity analyses were used to evaluate interstudy heterogeneity. Publication bias was evaluated using Egger's and Begg's linear tests. The global prevalence of MetS in patients with psoriasis was 32% (95% confidence interval [CI], 0.26–0.38). The prevalence in adults was 32% (95% CI, 0.29–0.36), while that in children and adolescents was 9% (95% CI, 0.00–0.18). Latin America had the highest prevalence of 47% (95% CI, 0.43–0.51), whereas North America had the lowest prevalence of 26% (95% CI, 0.16–0.37). Patients with psoriasis vulgaris (29%; 95% CI, 0.23–0.35) or severe psoriasis (37%; 95% CI, 0.27–0.46) had a higher prevalence of MetS than those with other psoriasis types. These findings suggest that MetS should be appropriately recognized and managed in patients with psoriasis. More population‐based prospective observational studies are required to elucidate the mechanisms underlying the coexistence of MetS in patients with psoriasis.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Global prevalence of metabolic syndrome in patients with psoriasis in the past two decades: current evidence

Liu

Cai

Sun

et al. 2022

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

“…This is important because the health status of psoriasis sufferers who smoked was worse than in non-smokers ( 16 ), and on the other hand smoking almost doubles the risk of psoriasis ( 17 ).The frequency of alcohol consumption was 24,80%. The results of other studies showed that alcohol use was higher in patients with psoriasis than in the control group ( 18 - 20 ). literature, 4 of 5 studies have shown alcohol as a risk factor for psoriasis ( 21 ).…”

Section: Discussionmentioning

confidence: 85%

Smoking Cigarettes and Consuming Alcohol in Patients with Psoriasis

Salihbegovic¹,

Kurtalić²,

Omerkic³

2021

Mater Sociomed

View full text Add to dashboard Cite

Introduction: Psoriasis is a chronic disease. Research shows the emergence of harmful habits such as cigarette smoking and alcohol consumption in people with psoriasis. Aim: The aim of this study was to determine the frequency of habits, cigarette smoking and alcohol consumption in patients with psoriasis, sexual distribution, and the relationship of habits with the severity of the disease. Methods: The prospective study included 129 subjects with psoriasis, of which 67 or 51,94% were women and 62 or 48,06% were men. Results: The frequency of cigarette smoking was 41,09%, alcohol consumption 24,80%. The gender distribution of cigarette smoking was: 35,82% of women and 46,77% of men smoked cigarettes. The gender distribution of alcohol consumption is: women 5,97% and men 45,16%. The severity of psoriasis, that is PASI score and cigarette smoking were statistically significantly related (r=0,63), and PASI score and alcohol consumption were not statistically significantly related (r=0,32). Conclusion: Cigarette smoking and alcohol consumption are present in psoriasis sufferers, cigarette smoking is associated with disease severity, and alcohol consumption is not. It takes knowledge of the habits of people with psoriasis and a multidisciplinary approach to get rid of harmful habits.

show abstract

“…All studies had an average age range between 35 and 53 years old, except one study in which children with an average age of 13 years old were under investigation 48 . Ninteen of 21 studies recorded that psoriasis patients are greatly more affected by MetS 29–32,35–49 . Howbeit, statistical analysis results, following the removal of adjusted variables in one study, were altered.…”

Section: Resultsmentioning

confidence: 99%

“… 48 Ninteen of 21 studies recorded that psoriasis patients are greatly more affected by MetS. 29 , 30 , 31 , 32 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 Howbeit, statistical analysis results, following the removal of adjusted variables in one study, were altered. It should be noted that in the mentioned study, after implementing the changes described above, a strong correlation between psoriasis and large waist size as well as high body mass index (BMI), was found.…”

Section: Resultsmentioning

confidence: 99%

Association between metabolic syndrome and prevalent skin diseases: A systematic review and meta‐analysis of case‐control studies

Sodagar,

Ghane,

Heidari

et al. 2023

Health Science Reports

View full text Add to dashboard Cite

Background and AimMetabolic syndrome (MetS) is a well‐known noncommunicable disease that plays a significant role in emerging other chronic disorders and following complications. MetS is also involved in the pathophysiology of numerous dermatological diseases. We aim to evaluate the association of MetS with the most prevalent dermatological diseases.MethodsA systematic search was carried out on PubMed, Science Direct, Web of Science, Cochrane, as well as the Google Scholar search engine. Only English case‐control studies regarding MetS and any skin disease from the beginning of 2010 up to November 15, 2022, were selected. The study was conducted based on the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis (PRISMA).ResultsA total of 37 studies (13,830 participants) met the inclusion criteria. According to our result, patients with psoriasis, hidradenitis suppurativa (HS), vitiligo, androgenetic alopecia (AGA), and lichen planus (LP) have a higher chance of having MetS compared to the general population. Furthermore, people with seborrheic dermatitis (SED) and rosacea are more prone to insulin resistance, high blood pressure (BP), and higher blood lipids. After pooling data, the meta‐analysis revealed a significant association between MetS and skin diseases (pooled odds ratio [OR]: 3.28, 95% confidence interval: 2.62−4.10). Concerning the type of disease, MetS has been correlated with AGA (OR: 11.86), HS (OR: 4.46), LP (OR: 3.79), and SED (OR: 2.45). Psoriasis also showed a significant association but with high heterogeneity (OR: 2.89). Moreover, skin diseases and MetS are strongly associated in Spain (OR: 5.25) and Thailand (OR: 11.86). Regarding the metaregression model, the effect size was reduced with increasing age (OR: 0.965), while the size increased with AGA (OR: 3.064).ConclusionsMetS is closely associated with skin complications. Dermatologists and other multidisciplinary teams should be cautious while treating these patients to prevent severe complications resulting from MetS.

show abstract

Addictive behaviors, cardiovascular and metabolic comorbidities in North African psoriatic patients: case-control study

Cited by 6 publications

References 32 publications

Global prevalence of metabolic syndrome in patients with psoriasis in the past two decades: current evidence

Global prevalence of metabolic syndrome in patients with psoriasis in the past two decades: current evidence

Smoking Cigarettes and Consuming Alcohol in Patients with Psoriasis

Association between metabolic syndrome and prevalent skin diseases: A systematic review and meta‐analysis of case‐control studies

Contact Info

Product

Resources

About